Estimates of effects, ranking, and certainty of evidence for different treatment options vs placebo
Everolimus + bevacizumab + SSA (1 RCT; 150 participants)
It is very uncertain whether estimates of effects, ranking, and certainty of evidence for… changes everolimus + bevacizumab + SSA (1 RCT; 150 participants) compared with placebo (very low certainty).
1 finding from 1 review
- Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta‐analysis 2021 · Cochrane Headline outcomes onlyHR 0.48 [0.28, 0.83]1 study · 150 participantsVery low